Routine upstream versus selective downstream administration of glycoprotein IIb/IIIa inhibitors in patients with non-ST-elevation acute coronary syndromes: a meta-analysis of randomized trials.
Sciahbasi
Alessandro
A
Policlinico Casilino-ASL RMB, Rome, Italy. alessandro.sciahbasi@fastwebnet.it
Biondi-Zoccai
Giuseppe
G
Romagnoli
Enrico
E
Valgimigli
Marco
M
Rasoul
Saman
S
van't Hof
Arnoud
A
Lioy
Ernesto
E
Stone
Gregg W
GW
D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D004562:Electrocardiography; D000077542:Eptifibatide; D006801:Humans; D010455:Peptides / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D016032:Randomized Controlled Trials as Topic; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D000077466:Tirofiban; D000077542:Eptifibatide